Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice
Joshua M. Borin, Roland Liu, Yanhan Wang, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

The gut virome is associated with stress-induced changes in behaviour and immune responses in mice
Nathaniel L. Ritz, Lorraine A. Draper, Thomaz F. S. Bastiaanssen, et al.
Nature Microbiology (2024) Vol. 9, Iss. 2, pp. 359-376
Open Access | Times Cited: 31
The human gut virome: composition, colonization, interactions, and impacts on human health
Evan Pargin, Michael J. Roach, Amber Skye, et al.
Frontiers in Microbiology (2023) Vol. 14
Open Access | Times Cited: 31
The Next Generation Fecal Microbiota Transplantation: To Transplant Bacteria or Virome
You Yu, Weihong Wang, Faming Zhang
Advanced Science (2023) Vol. 10, Iss. 35
Open Access | Times Cited: 24
Gut virome in inflammatory bowel disease and beyond
Hein M. Tun, Ye Peng, Luca Massimino, et al.
Gut (2023) Vol. 73, Iss. 2, pp. 350-360
Open Access | Times Cited: 23
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments
Torben Sølbeck Rasmussen, Xiaotian Mao, Sarah Förster, et al.
Microbiome (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 9
Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health
Daniel Kirk, Ricardo Costeira, Alessia Visconti, et al.
Cell Reports (2024) Vol. 43, Iss. 2, pp. 113728-113728
Open Access | Times Cited: 8
Targeted Gut Microbiome Therapy: Applications and Prospects of Probiotics, Fecal Microbiota Transplantation and Natural Products in the Management of Type 2 Diabetes
Luqi Qin, Bei Fan, Y. Zhou, et al.
Pharmacological Research (2025), pp. 107625-107625
Open Access | Times Cited: 1
Dynamics of Bacterial and Viral Transmission in Experimental Microbiota Transplantation
James Weagley, Heyde Makimaa, Luis Alberto Chica Cárdenas, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Transfer of modified gut viromes improves symptoms associated with metabolic syndrome in obese male mice
Xiaotian Mao, Sabina Birgitte Larsen, Line Fisker Zachariassen, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Fecal Microbiota Transplantation, a tool to transfer healthy longevity
Marta G. Novelle, Beatriz Naranjo-Martínez, Juan L López-Cánovas, et al.
Ageing Research Reviews (2024) Vol. 103, pp. 102585-102585
Open Access | Times Cited: 4
Opportunities and challenges in phage therapy for cardiometabolic diseases
Koen Wortelboer, Hilde Herrema
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 8, pp. 687-696
Closed Access | Times Cited: 3
The Role of Viruses in the Pathogenesis of Immune-Mediated Gastro-Intestinal Diseases
F Bernardi, Federica Ungaro, Ferdinando D’Amico, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 15, pp. 8301-8301
Open Access | Times Cited: 3
Bacteriophages and their potential for treatment of metabolic diseases
Youpeng Deng, Shouwei Jiang, Huawei Duan, et al.
Journal of Diabetes (2024) Vol. 16, Iss. 11
Open Access | Times Cited: 3
Intestinal flora and pregnancy complications: Current insights and future prospects
Zhenyu Tian, Xinjie Zhang, Guixiang Yao, et al.
iMeta (2024) Vol. 3, Iss. 2
Open Access | Times Cited: 2
Transfer of modified fecal viromes improve blood glucose regulation and alleviates symptoms of metabolic dysfunction-associated fatty liver disease in an obesity male mouse model
Xiaotian Mao, Sabina Birgitte Larsen, Line Fisker Zachariassen, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 6
Overcoming donor variability and risks associated with fecal microbiota transplants through bacteriophage-mediated treatments
Torben Sølbeck Rasmussen, Xiaotian Mao, Sarah Förster, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 4
Fecal Virome Transplantation (FVT) from healthy humans remodels the gut bacteriome and virome and reduces metabolic syndrome in mice
Melany Cervantes-Echeverría, Marco Antonio Jimenez-Rico, Rubiceli Manzo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Cryptic host phenotypic heterogeneity drives diversification of bacteriophage λ
Caesar A. De La Fuente, Nehme Lahoud, Justin R. Meyer
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Developmental Origins of Non-Communicable Chronic Diseases: Role of Fetal Undernutrition and Gut Dysbiosis in Infancy
M. Chandra
Children (2024) Vol. 11, Iss. 11, pp. 1387-1387
Open Access
Modulating intestinal viruses: A potential avenue for improving metabolic diseases with unresolved challenges
Xiaoxiao Cheng, Jie Yang, Zhijie Wang, et al.
Life Sciences (2024) Vol. 361, pp. 123309-123309
Closed Access
Reproducible chemostat cultures to minimize eukaryotic viruses from fecal transplant material
Signe Adamberg, Torben Sølbeck Rasmussen, Sabina Brigitte Larsen, et al.
iScience (2024) Vol. 27, Iss. 8, pp. 110460-110460
Open Access
Bacterial and viral assemblages in ulcerative colitis patients following fecal microbiota and fecal filtrate transfer
Howard Junca, Arndt Steube, Simon Mrowietz, et al.
ISME Communications (2024) Vol. 5, Iss. 1
Open Access
Page 1

Scroll to top